Feb 20, 2026 05:04AM
Feb 11, 2026 10:10AM
Jan 29, 2026 06:52AM
Jan 28, 2026 07:40AM
Jan 26, 2026 06:50AM
Jan 6, 2026 06:47AM
Dec 15, 2025 08:33AM OKYO Pharma chairman acquires 24,551 shares on NASDAQ
Dec 7, 2025 11:48PM
Dec 3, 2025 07:01AM
Nov 21, 2025 08:30AM
Oct 16, 2025 08:30AM
Sep 23, 2025 06:39AM
Sep 22, 2025 08:35AM
Jul 17, 2025 09:00AM OKYO Pharma receives $1.9 million in non-dilutive funding for drug development
Jul 17, 2025 06:50AM
Jun 11, 2025 10:05AM
Apr 30, 2025 07:04AM
Mar 31, 2025 08:04AM
Mar 10, 2025 08:32AM
Feb 18, 2025 06:49AM
Feb 12, 2025 07:01AM OKYO Pharma (OKYO) Announces OK-101 Officially Assigned USAN : Urcosimod
Feb 11, 2025 06:48AM
Jan 31, 2025 07:00AM
Jan 30, 2025 09:45AM
Jan 29, 2025 08:03AM
Jan 22, 2025 07:01AM
Nov 15, 2024 09:00AM
Oct 24, 2024 07:44AM H.C. Wainwright Reiterates Buy Rating on OKYO Pharma Ltd. (OKYO)
Oct 23, 2024 07:12AM
Oct 17, 2024 06:56AM
Oct 16, 2024 07:03AM
Sep 10, 2024 07:03AM
Sep 5, 2024 07:00AM
Aug 28, 2024 06:48AM
Aug 27, 2024 07:01AM OKYO Pharma (OKYO) Granted U.S. Patent Covering OK-101’s Potential for Treating Symptoms of Dry Eye Disease
Aug 23, 2024 09:00AM
Aug 21, 2024 07:01AM
Aug 6, 2024 07:01AM
Jul 12, 2024 08:18AM
Jul 11, 2024 10:32AM
Jul 11, 2024 07:01AM
Jul 10, 2024 07:00AM OKYO Pharma (OKYO) Reports Promising Categorical Data from OK-101 Trial

396,721 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All